Login / Signup
Editorial: golimumab thresholds to achieve stringent medium- and long-term therapeutic outcomes in patients with ulcerative colitis.
Gerassimos J Mantzaris
Konstantinos Papamichael
Published in:
Alimentary pharmacology & therapeutics (2022)
Keyphrases
</>
ulcerative colitis
ankylosing spondylitis
type diabetes
metabolic syndrome
systemic lupus erythematosus
skeletal muscle
weight loss